Revisiting Fosfomycin, a “Forgotten” Antibiotic | NIH: National Institute of Allergy and Infectious Diseases

Revisiting Fosfomycin, a “Forgotten” Antibiotic | NIH: National Institute of Allergy and Infectious Diseases

Tuesday, July 9, 2019 Revisiting Fosfomycin, a “Forgotten” Antibiotic In the ongoing fight against antibiotic resistance, NIAID supports studies of new therapeutics, as well as new uses for older, established antibiotics. In a new study, NIAID-supported researchers are investigating whether fosfomycin, an older antibiotic, can be safe and appropriate for treating lung infections when delivered through an IV, rather than taken by mouth. Learn more about the trial on the NIAID Now blog: